Literature DB >> 11955826

Partition coefficient, blood to plasma ratio, protein binding and short-term stability of 11-nor-Delta(9)-carboxy tetrahydrocannabinol glucuronide.

Gisela Skopp1, Lucia Pötsch, Martin Mauden, Barbara Richter.   

Abstract

11-Nor-Delta(9)-carboxy tetrahydrocannabinol glucuronide (THCCOOglu) is a major metabolite of tetrahydrocannabinol in blood. Despite its mass spectrometric identification already in 1980, further physicochemical data of THCCOOglu have not been established. Therefore, the octanol/buffer partition coefficient P and the blood to plasma ratio b/p for THCCOOglu concentrations of 100 and 500ng/ml were investigated. Protein binding of the glucuronide was established from spiked albumin solutions at a level of 250ng/ml as well as from authentic samples. The data were compared to those of 11-nor-Delta(9)-carboxy tetrahydrocannabinol (THCCOOH). In addition, the short-term stability of THCCOOglu in plasma at different storage temperatures was studied. Analysis was performed by LC/MS/MS. The glucuronide partition coefficient P (mean: 17.4 and 18.0 for 100 and 500ng/ml, respectively) was unexpectedly lipophilic at pH 7.4. Its blood to plasma ratios averaged 0.62 and 0.68 at 100 and 500ng/ml, respectively. THCCOOglu was highly reversibly bound to albumin (mean: 97%), and the mean fraction bound did not differ from that determined from authentic samples. THCCOOglu degraded even at a storage temperature of 4 degrees C and THCCOOH was identified as a major decomposition product.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11955826     DOI: 10.1016/s0379-0738(02)00023-3

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  11 in total

1.  Simultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometry.

Authors:  Karl B Scheidweiler; Nathalie A Desrosiers; Marilyn A Huestis
Journal:  Clin Chim Acta       Date:  2012-07-06       Impact factor: 3.786

Review 2.  Human cannabinoid pharmacokinetics.

Authors:  Marilyn A Huestis
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

3.  The postmortem redistribution of iso-α-acids in postmortem specimens.

Authors:  Luke N Rodda; Dimitri Gerostamoulos; Olaf H Drummer
Journal:  Forensic Sci Med Pathol       Date:  2014-10-16       Impact factor: 2.007

4.  Simultaneous quantitation of hydroxychloroquine and its metabolites in mouse blood and tissues using LC-ESI-MS/MS: An application for pharmacokinetic studies.

Authors:  Yashpal S Chhonker; Richard L Sleightholm; Jing Li; David Oupický; Daryl J Murry
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2017-11-23       Impact factor: 3.205

5.  Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC.

Authors:  Eugene W Schwilke; David M Schwope; Erin L Karschner; Ross H Lowe; William D Darwin; Deanna L Kelly; Robert S Goodwin; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2009-10-15       Impact factor: 8.327

6.  Intra- and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing.

Authors:  Eugene W Schwilke; Erin L Karschner; Ross H Lowe; Ann M Gordon; Jean Lud Cadet; Ronald I Herning; Marilyn A Huestis
Journal:  Clin Chem       Date:  2009-03-05       Impact factor: 8.327

7.  The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids.

Authors:  M L Holland; D T T Lau; J D Allen; J C Arnold
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

8.  Physiologically-based toxicokinetic modeling of zearalenone and its metabolites: application to the Jersey girl study.

Authors:  Dwaipayan Mukherjee; Steven G Royce; Jocelyn A Alexander; Brian Buckley; Sastry S Isukapalli; Elisa V Bandera; Helmut Zarbl; Panos G Georgopoulos
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

9.  Pharmacokinetics in Wistar Rats of 5-[(4-Carboxybutanoyl)Amino]-2-Hydroxybenzoic Acid: A Novel Synthetic Derivative of 5-Aminosalicylic Acid (5-ASA) with Possible Anti-Inflammatory Activity.

Authors:  Aurelio Romero-Castro; Mara Gutiérrez-Sánchez; José Correa-Basurto; Martha Cecilia Rosales Hernández; Itzia Irene Padilla Martínez; Jessica Elena Mendieta-Wejebe
Journal:  PLoS One       Date:  2016-07-25       Impact factor: 3.240

10.  High-Throughput Identification of Mammalian Secreted Proteins Using Species-Specific Scheme and Application to Human Proteome.

Authors:  Jian Zhang; Haiting Chai; Song Guo; Huaping Guo; Yanling Li
Journal:  Molecules       Date:  2018-06-14       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.